NOX-100 for Preventing Hypotension During Hemodialysis
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the safety, tolerability and efficacy profile of NOX-100
to reduce intradialytic hypotension (IDH) in patients undergoing chronic hemodialysis (HD).